Target intelligence / Profile preview

Claudin-7 (CLDN7)

Target
CLDN7
Molecular classification
Tight junction protein, Cell-adhesion protein, Integral membrane protein, Claudin family
01

Overview

Claudin-7 is an integral membrane protein and member of the claudin family that constitutes critical components of epithelial tight junctions. It has essential roles in regulating paracellular permeability, maintaining cell polarity, and supporting epithelial cell integrity. Claudin-7 also participates in the modulation of signaling pathways (such as Wnt/β-catenin), influences stem cell function in the intestinal crypts, and is involved in the maintenance of tissue homeostasis. Differential expression of claudin-7 is linked to cancer progression, invasion, EMT, and altered therapeutic resistance. Loss or dysfunction of claudin-7 leads to significant epithelial barrier defects and is associated with inflammatory and neoplastic diseases. No drugs are currently approved for direct targeting of claudin-7, but its expression has diagnostic, prognostic, and perhaps future therapeutic value

Other names
CLD7Claudin 7CLDN-7
02

Mechanism of action

Not established for direct therapeutic targeting. However, indirect mechanisms may involve modulation of tight junction integrity or alteration of associated signaling pathways (such as Wnt/β-catenin, PI3K/Akt)

03

Biological functions

Regulation of paracellular permeability (tight junction function)Maintenance of cell polarity and epithelial integrityRegulation of stem cell survival and differentiation via Wnt/β-catenin signalingParticipation in epithelial–mesenchymal transition (EMT) and cell-matrix interactionsCell-cell adhesion
04

Disease associations

Cancer (notably colorectal cancer, ovarian cancer, and others)Inflammation (roles in inflammatory bowel disease-like phenotypes)Broad tissue distribution and function suggest roles in multiple epithelial disorders
05

Safety considerations

Direct drug targeting of claudin-7 has theoretical risks including disruption of epithelial barrier function, increased permeability, and damage to normal tissue integrity
06

Biomarkers

Claudin-7 expression can serve as a biomarker for certain cancers (e.g., colorectal, ovarian) and for characterizing epithelial integrity and tumor phenotype

Beyond the preview

Go deeper on Claudin-7 (CLDN7).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Claudin-7 (CLDN7).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call